| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 6.38% | RBC Capital | $18 → $19 | Maintains | Sector Perform |
| 11/10/2023 | -4.82% | Piper Sandler | → $17 | Downgrades | Overweight → Neutral |
| 09/18/2023 | -4.82% | Piper Sandler | $24 → $17 | Maintains | Overweight |
| 09/14/2023 | 0.78% | Citigroup | $23 → $18 | Maintains | Neutral |
| 09/14/2023 | 28.78% | Baird | $28 → $23 | Maintains | Outperform |
| 09/14/2023 | 39.98% | Truist Securities | $32 → $25 | Maintains | Buy |
| 09/14/2023 | 0.78% | RBC Capital | $27 → $18 | Downgrades | Outperform → Sector Perform |
| 06/07/2023 | 56.77% | Baird | $28 → $28 | Maintains | Outperform |
| 05/19/2023 | 34.38% | Piper Sandler | $32 → $24 | Maintains | Overweight |
| 05/18/2023 | 51.18% | RBC Capital | $30 → $27 | Maintains | Outperform |
| 05/18/2023 | 56.77% | Baird | $32 → $28 | Maintains | Outperform |
| 05/18/2023 | 28.78% | Citigroup | $30 → $23 | Maintains | Neutral |
| 04/20/2023 | 79.17% | Baird | $32 → $32 | Maintains | Outperform |
| 02/16/2023 | 79.17% | Baird | $30 → $32 | Maintains | Outperform |
| 02/16/2023 | 67.97% | RBC Capital | $26 → $30 | Maintains | Outperform |
| 02/16/2023 | 79.17% | Credit Suisse | $27 → $32 | Maintains | Buy |
| 02/16/2023 | 79.17% | Piper Sandler | $29 → $32 | Maintains | Overweight |
| 01/24/2023 | 67.97% | Baird | $26 → $30 | Maintains | Outperform |
| 01/06/2023 | 62.37% | Piper Sandler | $27 → $29 | Maintains | Overweight |
| 11/18/2022 | 45.58% | Citigroup | $18 → $26 | Maintains | Neutral |
| 11/16/2022 | 51.18% | Truist Securities | $22 → $27 | Maintains | Buy |
| 11/16/2022 | 45.58% | RBC Capital | $20 → $26 | Maintains | Outperform |
| 11/16/2022 | 51.18% | Piper Sandler | $20 → $27 | Maintains | Overweight |
| 09/26/2022 | 23.18% | Truist Securities | $26 → $22 | Maintains | Buy |
| 09/26/2022 | 0.78% | Citigroup | $20 → $18 | Maintains | Neutral |
| 09/23/2022 | 11.98% | RBC Capital | $22 → $20 | Maintains | Outperform |
| 09/23/2022 | 11.98% | Piper Sandler | $21 → $20 | Maintains | Overweight |
| 07/19/2022 | 11.98% | Citigroup | $21 → $20 | Downgrades | Buy → Neutral |
| 07/18/2022 | 17.58% | Piper Sandler | $17 → $21 | Maintains | Overweight |
| 05/19/2022 | -4.82% | Piper Sandler | $20 → $17 | Maintains | Overweight |
| 02/17/2022 | 11.98% | Piper Sandler | $18 → $20 | Maintains | Overweight |
| 01/13/2022 | 0.78% | Piper Sandler | $21 → $18 | Maintains | Overweight |
| 12/22/2021 | 11.98% | Baird | → $20 | Maintains | Outperform |
| 11/24/2021 | 17.58% | Citigroup | $23 → $21 | Maintains | Buy |
| 11/23/2021 | 23.18% | RBC Capital | $24 → $22 | Maintains | Outperform |
| 11/23/2021 | 17.58% | Piper Sandler | $22 → $21 | Maintains | Overweight |
| 10/26/2021 | 56.77% | Baird | → $28 | Maintains | Outperform |
| 09/16/2021 | 28.78% | Citigroup | $29 → $23 | Maintains | Buy |
| 09/15/2021 | 23.18% | Piper Sandler | $25 → $22 | Maintains | Overweight |
| 12/11/2020 | 39.98% | Piper Sandler | $19 → $25 | Maintains | Overweight |
| 11/20/2020 | 0.78% | Citigroup | $22 → $18 | Maintains | Buy |
| 11/17/2020 | 6.38% | Piper Sandler | $18 → $19 | Maintains | Overweight |
| 09/25/2020 | 0.78% | Piper Sandler | $20 → $18 | Maintains | Overweight |
| 09/01/2020 | 23.18% | Truist Securities | → $22 | Initiates Coverage On | → Buy |
| 09/01/2020 | 23.18% | Citigroup | → $22 | Initiates Coverage On | → Buy |
| 09/01/2020 | 23.18% | Baird | → $22 | Initiates Coverage On | → Outperform |
| 09/01/2020 | 28.78% | RBC Capital | → $23 | Initiates Coverage On | → Outperform |
| 09/01/2020 | 11.98% | Piper Sandler | → $20 | Initiates Coverage On | → Overweight |
What is the target price for IBEX (IBEX)?
The latest price target for IBEX (NASDAQ: IBEX) was reported by RBC Capital on November 10, 2023. The analyst firm set a price target for $19.00 expecting IBEX to rise to within 12 months (a possible 6.38% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IBEX (IBEX)?
The latest analyst rating for IBEX (NASDAQ: IBEX) was provided by RBC Capital, and IBEX maintained their sector perform rating.
When is the next analyst rating going to be posted or updated for IBEX (IBEX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IBEX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IBEX was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
Is the Analyst Rating IBEX (IBEX) correct?
While ratings are subjective and will change, the latest IBEX (IBEX) rating was a maintained with a price target of $18.00 to $19.00. The current price IBEX (IBEX) is trading at is $17.86, which is out of the analyst's predicted range.